V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250012530 | 250007666 | null | 95.3 | Disease modification (D) | 2015-10-26 | 2016-03-12 | Busulfan Oral | N | N | 250030050 | RITUXIMAB |
| 250012533 | 250007695 | 1.57 | 77 | Palliative (P) | null | 2014-12-07 | GEMCARBO | 2 | N | 250030280 | FLUDARABINE + MELPHALAN |
| 250012535 | 250007709 | 1.7 | 72.8 | null | null | 2017-09-17 | Rituximab | 02 | N | 250030354 | DOCETAXEL |
| 250012536 | 250012102 | 0 | 96 | Palliative (P) | 2018-02-21 | 2018-06-09 | Cytarabine High Dose | N | N | 250030520 | CARBOPLATIN |
| 250012537 | 250007729 | null | 45.5 | Palliative (P) | 2015-10-19 | 2015-10-24 | Pemetrexed | Y | N | 250030531 | GEMCARBO |
| 250012538 | 250007755 | 1.77 | 111 | Palliative (P) | 2016-07-06 | 2016-07-06 | CARBOPLATIN | 02 | N | 250030761 | IPM |
| 250012539 | 250007760 | null | 52.2 | Not known (9) | 2015-06-25 | 2015-11-26 | DA 3+8 | 02 | N | 250030799 | IPM |
| 250012540 | 250007764 | 1.79 | 117 | Palliative (P) | 2016-11-05 | 2019-03-30 | BENDAMUSTINE + RITUXIMAB | 2 | N | 250030817 | SPIRE TRIAL |
| 250012542 | 250007773 | 1.47 | 81.4 | Palliative (P) | 2017-08-26 | 2017-08-26 | ANAGRELIDE | N | N | 250030855 | DA |
| 250012543 | 250007777 | 0 | 74.6 | Palliative (P) | 2016-08-26 | 2016-09-15 | Epirubicin | 2 | N | 250030856 | GEMCITABINE |
| 250012544 | 250007787 | 1.83 | 61.2 | Palliative (P) | 2015-05-12 | 2015-05-12 | DA 3 + 10 | N | N | 250030917 | GEMCARBO |
| 250012545 | 250007789 | 1.78 | 86 | Palliative (P) | 2015-06-13 | 2015-06-20 | Carboplatin AUC 2 - 5 | 02 | null | 250030918 | BORTEZOMIB |
| 250012546 | 250007800 | 0 | 139 | Palliative (P) | null | 2014-04-30 | Cisplatin 100 + RT(H&N) 1 day | 2 | N | 250031024 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB |
| 250012547 | 250007809 | 1.7 | 70 | Palliative (P) | 2015-07-11 | 2015-08-10 | CARBOPLATIN + PACLITAXEL | 2 | N | 250031099 | GEMCARBO |
| 250012548 | 250010908 | null | 83.8 | Disease modification (D) | 2014-03-29 | 2014-06-11 | Paclitaxel 7 day | N | N | 250031196 | CARBOPLATIN + VINORELBINE |
| 250012549 | 250010912 | 0 | 67 | Palliative (P) | 2017-05-02 | 2017-05-31 | IPM | N | N | 250031247 | IPM |
| 250012550 | 250007828 | null | null | Palliative (P) | 2013-04-19 | 2013-04-26 | PEG INTERFERON | 2 | N | 250031269 | PEMETREXED |
| 250012552 | 250007840 | null | null | Disease modification (D) | 2018-09-04 | 2018-09-04 | GEMCARBO | N | null | 250031300 | GEMCARBO |
| 250012553 | 250007845 | 1.81 | 70 | null | 2015-07-07 | 2017-07-05 | Mitoxantrone | 02 | N | 250031323 | IPM |
| 250012554 | 250007859 | 1.8 | 0 | Palliative (P) | 2018-04-14 | 2018-04-20 | Mitoxantrone | 2 | N | 250031419 | CARBOPLATIN |
| 250012555 | 250007865 | null | null | Curative (C) | 2016-03-07 | 2016-08-08 | BUSULFAN | N | N | 250031490 | GEMCARBO |
| 250012556 | 250007881 | null | 118.3 | Palliative (P) | 2017-12-20 | 2018-01-17 | Bevacizumab | 02 | N | 250031622 | CARBOPLATIN + PACLITAXEL |
| 250012557 | 250007882 | 1.69 | 72 | Palliative (P) | 2017-01-14 | 2017-02-08 | GemCarbo Days 1+8 | 02 | N | 250031624 | CYTARABINE |
| 250012558 | 250007885 | 1.78 | 83.7 | Palliative (P) | 2015-11-07 | 2015-11-10 | DA | 02 | N | 250031648 | IPM |
| 250012559 | 250010940 | null | null | Palliative (P) | 2016-02-08 | 2016-02-21 | Pemetrexed | 2 | N | 250031685 | GEMCITABINE |
| 250012560 | 250007897 | 1.7 | 69.4 | Curative (C) | 2013-12-19 | 2016-02-21 | IPM | 02 | N | 250031746 | COMMAND TRIAL |
| 250012561 | 250010944 | 1.68 | 56.2 | Palliative (P) | 2017-04-22 | 2017-06-27 | IPM | 02 | N | 250031764 | GEMCITABINE |
| 250012562 | 250007913 | 1.74 | 83.8 | Palliative (P) | 2014-03-25 | 2014-04-25 | Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE | 02 | N | 250031866 | GEMCARBO |
| 250012563 | 250007916 | null | 66.6 | Not known (9) | 2015-03-31 | 2015-03-31 | GemCarbo Days 1+8 | null | null | 250031889 | CARBOPLATIN |
| 250012564 | 250007921 | null | 42 | Adjuvant (A) | null | 2015-08-26 | GemCarbo Days 1+8 | 2 | Y | 250031917 | GEMCARBO |
| 250012565 | 250007924 | 1.82 | 49.8 | Palliative (P) | 2016-06-08 | 2016-10-25 | GemCarbo Days 1+8 | N | N | 250031935 | IPM |
| 250012566 | 250007935 | 1.71 | null | Not known (9) | 2014-07-20 | 2014-11-29 | GEMCARBO | 02 | N | 250031988 | LENALIDOMIDE |
| 250012567 | 250010964 | 1.73 | 62 | Curative (C) | 2018-09-30 | 2018-09-30 | Cyclophosphamide Fludarabine (Oral) | 02 | N | 250032030 | PEMETREXED |
| 250012568 | 250007944 | 1.52 | 61.2 | Neo-adjuvant (N) | 2013-06-19 | 2016-10-04 | AML LI-1 Trial | 2 | N | 250032041 | GEMCARBO |
| 250012569 | 250007949 | 1.68 | 61 | Curative (C) | 2017-02-22 | 2017-02-22 | GemCarbo Days 1+8 | 2 | N | 250032081 | CARBOPLATIN + DOXORUBICIN |
| 250012570 | 250007957 | 1.8 | 67 | Curative (C) | 2014-08-28 | 2014-08-28 | IPM | N | N | 250032114 | AML17 TRIAL |
| 250012571 | 250007959 | 1.68 | 80.4 | Curative (C) | null | 2014-04-09 | GemCarbo Days 1+8 | 02 | N | 250032117 | GEMCARBO |
| 250012572 | 250007968 | 1.71 | 49 | Palliative (P) | 2017-08-10 | 2017-08-11 | GEMCARBO | N | N | 250032206 | RADIUM 223 |
| 250012573 | 250007982 | null | null | Palliative (P) | 2014-09-09 | 2015-04-09 | PEMBROLIZUMAB | N | null | 250032261 | AZACITIDINE |
| 250012574 | 250007990 | null | 44 | Curative (C) | 2019-08-17 | 2019-08-19 | COMMAND trial | null | N | 250032303 | IPM |
| 250012575 | 250010980 | null | null | Disease modification (D) | 2016-10-18 | 2018-05-18 | GemCarbo Days 1+8 | N | N | 250032349 | CISPLATIN |
| 250012576 | 250010982 | 1.56 | 75 | Curative (C) | 2017-01-29 | 2017-01-29 | IPM | null | N | 250032350 | CISPLATIN + GEMCITABINE |
| 250012577 | 250012879 | null | null | Palliative (P) | 2014-12-05 | 2014-12-05 | BUSULFAN | N | N | 250032351 | IPM |
| 250012578 | 250008007 | 1.73 | 65.6 | Palliative (P) | 2015-06-09 | 2015-12-02 | PEMBROLIZUMAB | 02 | N | 250032396 | CARBOPLATIN + PACLITAXEL |
| 250012579 | 250008016 | null | 78.6 | Palliative (P) | null | 2014-08-21 | Eribulin | N | N | 250032456 | GEMCARBO |
| 250012580 | 250012157 | 1.65 | 0 | Neo-adjuvant (N) | 2017-05-21 | 2017-09-16 | Epirubicin (weekly) | 02 | N | 250032511 | COMMAND TRIAL |
| 250012581 | 250008031 | 1.55 | 69 | Palliative (P) | 2014-09-02 | 2014-09-03 | Pipobroman | 2 | N | 250032537 | BORTEZOMIB |
| 250012582 | 250008046 | null | 78.3 | Adjuvant (A) | 2014-02-19 | 2014-02-23 | IPM | 2 | N | 250032607 | CYTARABINE |
| 250012583 | 250008050 | 1.6 | 83.7 | Palliative (P) | 2014-11-10 | 2017-07-10 | FEC + DOCETAXEL | N | N | 250032650 | VENETOCLAX |
| 250012584 | 250008056 | null | 80 | Palliative (P) | 2011-09-28 | 2015-05-31 | Rituximab (Maintenance) | 02 | N | 250032724 | PEMETREXED |